HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antipyrine metabolism in patients with liver metastases from colorectal cancer.

AbstractBACKGROUND:
The influence of cancer on antipyrine metabolism is under debate.
METHODS:
To assess the functional activity of a liver with solid metastases from primary colorectal cancer, antipyrine metabolism was studied after the drug was administered orally (18 mg/kg body weight) to 55 healthy volunteers, 62 patients with well-compensated cirrhosis, and 42 patients with small (Class A) or massive (Class B) metastatic liver involvement.
RESULTS:
In patients with cancer, antipyrine clearance (0.472 +/- 0.177 ml/min/kg) was similar to that in healthy volunteers (0.456 +/- 0.198 ml/min/kg) and significantly higher than in those with cirrhosis (0.259 +/- 0.17 ml/min/kg, P less than 0.001). There was no difference in antipyrine pharmacokinetics between Class A and B involvement. In the entire population, antipyrine clearance was correlated with serum albumin levels (r = 0.294, P = 0.0002) and prothrombin activity (r = 0.416, P = 0.001). This positive correlation was not present when only the neoplastic group was considered. No correlation was found between antipyrine clearance and alkaline phosphatase levels. In patients with cancer, no relationship was found between antipyrine clearance and carcinoembryonic antigen and lactic dehydrogenase levels.
CONCLUSIONS:
These results show that patients with livers largely replaced by solid metastases are able to metabolize antipyrine to the same extent as healthy subjects.
AuthorsA Grieco, C Barone, P Coletta, R Castellano, E Ragazzoni, A Cassano, A Astone, G Gambassi
JournalCancer (Cancer) Vol. 70 Issue 6 Pg. 1477-82 (Sep 15 1992) ISSN: 0008-543X [Print] United States
PMID1515999 (Publication Type: Journal Article)
Chemical References
  • Antipyrine
Topics
  • Adult
  • Aged
  • Antipyrine (pharmacokinetics)
  • Colorectal Neoplasms (pathology)
  • Female
  • Humans
  • Liver Cirrhosis (metabolism)
  • Liver Function Tests
  • Liver Neoplasms (metabolism, secondary)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: